EGAN vs APPN Stock Comparison

Egain and Appian Prices as of Oct 23, 2026 Peers: Industry group
EGAN EGAIN Corp
$5.68 -4.2% 1M -60.9% 1Y
Market cap
$152.36M
P/E
17.4x
Revenue (TTM)
—
Div. yield
–
Business Process Automation Technology
2 wins
APPN Appian Corp
$52.35 +37.9% 1M +68.6% 1Y
Market cap
$3.76B
P/E
–
Revenue (TTM)
$795.31M
Div. yield
–
Business Process Automation Technology
3 wins

Head to Head

5 decided of 12

Appian leads on 3 of the 12 questions below (Appian 3, Egain 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionEGANAPPNLeader
Larger companyMarket capitalisation $152.36M $3.76B APPN
Cheaper on earningsLower P/E, profitable companies only 17.4x -353.8x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 113.6x 46.7x APPN
Faster revenue growthRevenue growth, trailing twelve months — +20.9% –
More profitableNet margin, trailing twelve months — -1.3% –
Better return on capitalReturn on invested capital — 6.5% –
Less leveragedLower net debt / EBITDA — 3.4x –
Higher dividend yieldTrailing dividend yield 0.00% 0.00% –
Better 1-year returnPrice return, last 12 months -60.9% +68.6% APPN
Better 5-year returnAnnualised price return, 5 years -11.1%/yr -11.2%/yr EGAN
Less volatileAnnualised volatility, 1 year 60.7% 68.2% EGAN
Higher overall scoreMean of the five percentile scores vs peers — 51/100 –

Percentile Scorecard

EGANAPPN

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisEGANAPPN
Valuation 96 #5 of 101 41 #60 of 101
Growth – 91 #10 of 97
Profitability – 55 #43 of 94
Financial Health 79 #24 of 109 32 #75 of 109
Shareholder Returns – 38 #40 of 64
Overall – 51
  • EGAN ranked among 114 companies in Business Applications
  • APPN ranked among 114 companies in Business Applications

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodEGANAPPNSPY
1 month -4.2%+37.9% -1.0%
3 months -11.4%+120.4% +2.9%
6 months -24.1%+136.3% +6.4%
Year to date -44.8%+47.8% +11.4%
1 year -60.9%+68.6% +13.1%
3 years -8.1%+25.8% +79.4%
3 years, per year -2.8%+8.0% +21.5%
5 years -44.4%-44.9% +67.7%
5 years, per year -11.1%-11.2% +10.9%
10 years +89.3%— +255.2%
10 years, per year +6.6%— +13.5%

Risk

MeasureEGANAPPNSPY
Volatility, 1Y 60.7%68.2% 12.7%
Downside volatility, 1Y 71.1%59.7% 12.7%
Beta vs S&P 500, 1Y 1.660.51 1.00
Return / volatility, 1Y -1.001.01 1.03
Max drawdown, 5Y -66.9%-81.9% -25.4%
From 52-week high -63.3%0.0% -2.5%
52-week high $15.46$52.35 $779.14
52-week low $5.11$18.72 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleEGANAPPN
P/E now vs peer median 17.4xmedian 29.9x -359.3xmedian 29.9x
P/S now vs peer median 1.6xmedian 2.8x 4.7xmedian 2.8x
EV/EBITDA now vs peer median —median 17.4x 188.9xmedian 17.4x
P/FCF now vs peer median 7.2xmedian 16.9x 49.0xmedian 16.9x
P/B now vs peer median 1.8xmedian 3.1x -35.7xmedian 3.1x
PEG now vs peer median —median 0.86 -6.06median 0.86

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsEGANAPPN
Revenue – $795.31M
Gross profit – $565.62M
Operating income – $10.14M
Net income – -$10.62M
Free cash flow – $76.75M
R&D – $185.95M
EPS (diluted) – $-0.15
Cash & equivalents $73.34M $121.11M
Total debt – $236.03M
Shares (diluted) 27.86M 72.90M
Enterprise value -$137.85M $3.01B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricEGANAPPN
P/E 17.4x -359.3x
P/FCF 7.2x 49.0x
P/Operating cash flow – 46.5x
P/S 1.6x 4.7x
P/B 1.8x -35.7x
P/Tangible book 1.8x -35.5x
EV/EBITDA – 188.9x
EV/EBIT – 377.3x
EV/Revenue – 4.8x
EV/FCF – 49.9x
EV/Operating cash flow – 47.4x
PEG (3Y EPS CAGR) – -6.06

Growth

14 metrics
MetricEGANAPPN
Revenue growth (1Y) – 20.9%
Revenue CAGR (3Y) – 16.2%
Gross profit growth (1Y) – 19.3%
Gross profit CAGR (3Y) – 15.8%
Operating income growth (1Y) – 172.8%
Operating income CAGR (3Y) – 27.4%
Net income growth (1Y) – 38.4%
Net income CAGR (3Y) – 59.3%
EPS growth (1Y) – 37.3%
EPS CAGR (3Y) – 59.3%
Operating cash flow growth (1Y) – 66.0%
Operating cash flow CAGR (3Y) – 42.0%
Free cash flow growth (1Y) – 66.9%
Free cash flow CAGR (3Y) – 39.7%

Profitability

14 metrics
MetricEGANAPPN
Gross margin – 71.1%
EBITDA margin – 2.5%
Operating margin – 1.3%
Pretax margin – -0.7%
Net margin – -1.3%
FCF margin – 9.6%
Operating cash flow margin – 10.2%
Return on equity – –
Return on assets – -1.8%
Return on invested capital – 6.5%
Return on capital employed – 5.3%
Asset turnover – 1.3x
Cash conversion (OCF / net income) – -7.6x
Stock comp / revenue – 5.4%

Financial Health

11 metrics
MetricEGANAPPN
Debt / assets – 40.3%
Debt / equity – -2.2x
Net debt / EBITDA – 3.4x
Debt / FCF – 3.1x
Liabilities / assets 43.1% 118.0%
Equity / assets 56.9% -18.0%
Interest coverage – 0.6x
Current ratio 1.7x 1.0x
Quick ratio 1.7x 0.8x
Cash ratio 1.2x 0.4x
Altman Z-score – 3.18

Shareholder Returns

7 metrics
MetricEGANAPPN
Dividend yield – –
Net buyback yield – 2.0%
Shareholder yield – 2.0%
Payout ratio (earnings) – –
Payout ratio (FCF) – –
Dividend growth (1Y) – –
Dividend CAGR (3Y) – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusEGANAPPN
Forward P/E 113.6xFY2027 46.7xFY2026
EPS, next fiscal year $0.05FY2027 $1.12FY2026
EPS growth, next FY -89.4%FY2027 +83.6%FY2026
EPS growth, the year after -60.0% +20.5%
Revenue, next fiscal year $89.04MFY2027 $897.68MFY2026
Revenue growth, next FY -2.3%FY2027 +23.5%FY2026
Revenue growth, the year after -12.3% +12.0%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersEGANAPPN
Held by institutions 53.0% 94.9%
Institutions holding 106 212
Change in shares held, QoQ -1.1% -1.3%
Institutions buying 55 120
Institutions selling 34 52
Buyers to sellers 1.62 2.31

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

EGANAPPN
EGAN 1.00 0.31
APPN 0.31 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, EGAN and APPN?

Appian (APPN) is the largest by market capitalisation: Egain (EGAN) $152.36M, Appian (APPN) $3.76B.

Which stock has performed better?

Over the past year Appian (APPN) returned the most: Egain (EGAN) -60.9%, Appian (APPN) +68.6%. Over five years, Egain (EGAN) compounded fastest (Egain (EGAN) -11.1%/yr, Appian (APPN) -11.2%/yr). Returns are price only, before dividends.

Which stock is riskier?

By one-year price volatility, Egain (EGAN) has been the steadiest (Egain (EGAN) 60.7%, Appian (APPN) 68.2%). Volatility measures how widely the price swings, not the risk of the business.

Do EGAN and APPN move together?

Their daily returns over the past year have a correlation of 0.31, a weak relationship. Holding both diversifies more than two closely linked stocks would.

Which is the better stock, EGAN and APPN?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Appian (APPN) leads on 3. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.